Literature DB >> 16397580

Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells.

M Macaluso1, M Montanari, C M Marshall, A J Gambone, G M Tosi, A Giordano, M Massaro-Giordano.   

Abstract

Extracellular plasminogen activator inhibitor type-2 (PAI-2) is a potent inhibitor of urokinase-type plasminogen activator (u-PA) and also acts as a multifunctional protein. However, the biological activity of intracellular PAI-2, as well as its intracellular targets, until now remain an enigma. Here, we show that pRb2/p130 and Rb1/p105, but not p107, interact with PAI-2 in both the cytoplasm and nucleus of normal primary human corneal and conjunctival epithelial cells. We provided the first in vivo evidence that a specific fragment of the PAI-2 promoter is bound simultaneously by pRb2/ p130, PAI-2, E2F5, histone deacetylase 1 (HDAC1), DNA methyltransferase 1 (DNMT1), and histone methyltransferase (SUV39H1), in normal primary human corneal epithelial cells, and by pRb2/p130, PAI-2, E2F5, HDAC1, and DNMT1, in normal primary human conjunctiva epithelial cells. Our results strongly indicate a physiological interaction between pRb family members and PAI-2, suggesting the hypothesis that pRb2/p130 and PAI-2 may cooperate in modulating PAI-2 gene expression by chromatin remodeling, in normal corneal and conjunctival cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397580     DOI: 10.1038/sj.cdd.4401835

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  3 in total

1.  Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli.

Authors:  Joanna Boncela; Patrycja Przygodzka; Izabela Papiewska-Pajak; Elzbieta Wyroba; Czeslaw S Cierniewski
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

2.  Tumour Expression of Histone Deacetylases in Uveal Melanoma.

Authors:  Louis Levinzon; Michele Madigan; Vuong Nguyen; Enisa Hasic; Max Conway; Svetlana Cherepanoff
Journal:  Ocul Oncol Pathol       Date:  2018-09-18

3.  UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation.

Authors:  Cheng Du; Hong Wu; Roger P Leng
Journal:  Oncotarget       Date:  2016-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.